DOES CISATRACURIUM AT A CLINICAL DOSE ATTENUATE THE IMMUNOSUPPRESSION AFTER SURGERY IN SMOKING PATIENTS WITH NON-SMALL CELL LUNG CANCER? [electronic resource]
Producer: 20160229Description: 375-7 p. digitalISSN:- 0544-0440
- Atracurium -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- pathology
- Humans
- Immunocompromised Host -- drug effects
- Lung Neoplasms -- pathology
- Neuromuscular Blocking Agents -- administration & dosage
- Postoperative Complications -- immunology
- Smoking -- adverse effects
- Stress, Physiological -- immunology
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.